gritstone oncology is a cancer immunotherapy company developing next-generation personalized cancer therapeutics. gritstone brings together distinguished scientific founders, an experienced and diverse management team, a seasoned and successful board of di

Gritstone bio, Inc. Common Stock

Bought 7% more GRTS

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Carlos Rebolledo

Bought 3% more GRTS

Bought 4% more GRTS

Bought 5% more GRTS

Bought 6% more GRTS

Sold all GRTS

Mike Pelech

Sold 35% of GRTS

Bought 37% more GRTS

Bought 59% more GRTS